Home › Encyclopedia › N-Acetyl Selank: Research Status and Compound Overview
Research / Unapproved

N-Acetyl Selank: Research Status and Compound Overview

Molecular formulaC35H59N11O10
Molecular weight793.9 g/mol
Registered trials0
PubChem CID133082488

Anyone researching N-Acetyl Selank will find very little formal documentation to draw on. This overview covers only what is verifiable: its chemical identity and its current regulatory and trial status.

Key takeaways

  • N-Acetyl Selank has no FDA-approved label and is classified as an unapproved research compound.
  • No clinical trials for this compound are currently registered.
  • Its molecular formula is C35H59N11O10, with a molecular weight of about 793.9 g/mol.
  • No adverse event reports are currently available for this compound.

What N-Acetyl Selank is

N-Acetyl Selank is a synthetic peptide identified by PubChem CID 133082488. There is no FDA-approved drug label associated with this compound, and no mechanism of action or pharmacological class has been established through regulatory review. Because no label exists, any claims about its biological activity fall outside verified data and are not addressed here.

Trial footprint

There are currently no clinical trials registered for N-Acetyl Selank. This means there is no publicly tracked human research record for this compound at this time.

FAQ

Is N-Acetyl Selank FDA approved?
No. N-Acetyl Selank has no FDA-approved label and is classified as an unapproved research compound. It has not undergone the regulatory review process required for approval.
How many clinical trials have studied N-Acetyl Selank?
There are currently zero registered clinical trials for N-Acetyl Selank. No human trial data is publicly tracked for this compound at this time.
What is the chemical makeup of N-Acetyl Selank?
N-Acetyl Selank has the molecular formula C35H59N11O10 and a molecular weight of approximately 793.9 g/mol. It is catalogued in PubChem under CID 133082488.
Are there known side effects of N-Acetyl Selank?
No adverse event data is currently available for this compound. Because it lacks an approved label and clinical trial history, no side effect profile has been established.
Does N-Acetyl Selank have an established mechanism of action?
No mechanism of action has been documented, since there is no FDA label or clinical research record for this compound. Any such claims elsewhere are not supported by verified regulatory or trial data.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 133082488

Updated 2026-08-15